A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1500 participants.

Also called NCT06168942

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,500 participants (planned count) (from the registry)
Sponsor
Jaguar LAA, Inc. (from the registry)
Registry
  • NCT NCT06168942
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT06168942. Randomized; no masking; primary purpose treatment. Start 2024-02-19 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
Condition
Non-valvular Atrial Fibrillation
Condition
Stroke
Condition
Systemic Embolism
Intervention (Device)
Experimental: Laminar Left Atrial Appendage Closure System
Intervention (Device)
Active Comparator: WATCHMAN / Amulet
Lead sponsor
Jaguar LAA, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06168942
Content hash
3bf54641a17d18ff69e4993329715e63c374c7e52e01dc3bc44db35b8dd15288